Pfizer and BioNTech Start Phase 1/2 Study of First mRNA-based Shingles Vaccine in the US
Pfizer and BioNTech plan to use mRNA technology to meet the demand for highly effective, well-tolerated, and effectively manufactured shingles
Read morePfizer and BioNTech plan to use mRNA technology to meet the demand for highly effective, well-tolerated, and effectively manufactured shingles
Read moreThe acquisition agreement is set to expand Aegis’s toxicology portfolio, while HealthTrackRx expands its PCR infectious disease testing. Aegis Sciences
Read moreThermo Fisher Scientific, the global leader in serving science, announced the launch of the TrueMark Infectious Disease Research Panels designed
Read moreModerna Inc will make investments in mRNA research and development (R&D) in the UK and construct a cutting-edge facility for
Read moreThe US Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for Novavax’s adjuvanted Covid-19 vaccine, NVX-CoV2373, as
Read moreApogenix, a biopharmaceutical company developing next-gen immunotherapeutics, announced on Wednesday that asunercept showed statistically meaningful benefits for hospitalized COVID-19 patients
Read moreTinytag temperature data loggers are being utilised for the monitoring of vaccines and medications through the pharmaceutical cold chain. Temperature
Read moreWith the EchoLUTION SARS-CoV-2 RNA Kit, the PCR test of COVID-19 samples can be drastically accelerated. Ultra-fast COVID-19 PCR testing
Read moreAmerican biotech Oragenics, Inc. announced on Thursday the posting of a preprint manuscript in bioRxiv (pronounced “bio-archives”) evaluating a novel
Read moreThe first doses of an experimental HIV vaccine antigen have been provided in a clinical study at George Washington University
Read more